Medical device maker Medtronic Plc on Tuesday projected revenue rose to $7.3 billion in the fourth quarter, its first to include results from Covidien Plc, and earnings would be at the upper end of its previously forecast range.
Analysts on average were expecting revenue of $7.08 billion, according to Thomson Reuters I/B/E/S.
Medtronic said fourth-quarter cash earnings, excluding charges, would be in the upper half of a range of $1.08 to $1.13.
The preliminary quarterly results were the first to include revenue generated by Covidien Plc, which Medtronic acquired in January for $49.9 billion.
Publications
Dec 2019 ebook
The way we perceive care-giving is continuously changing and the demand for speedy processes is more than ever. The industry leaders have already defined that empowering processes is the way out to keep up with the changing landscape of global healthcare needs.
Keeping Process Driven Approach as our top priority, we introduce our latest edition of Hospital & Healthcare Management Magazine with a spotlight on this impeccable move to eminence.
